Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments
APMIS · 2026-03 · 134 (3)
DOI: 10.1111/apm.70166 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift APMIS, online erschienen am 10.03.2026. Verfasst von Lourdes Serrano Garcia und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil. Hauptthemen laut MEDLINE: Biofilms, Mycobacterium tuberculosis, Antitubercular Agents, Drug Tolerance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, São Paulo Research Foundation, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Biofilms formed by mycobacteria, particularly Mycobacterium tuberculosis (Mtb), represent a major challenge in tuberculosis (TB) treatment due to their highly organized structure and their capacity to induce phenotypic drug tolerance. These three‐dimensional bacterial aggregates are embedded in a self‐produced extracellular matrix that restricts antibiotic penetration and shields bacilli from host immune responses. The resulting spatial and physiological heterogeneity within biofilms generates microenvironments that favor slow‐growing or non‐replicating cells, markedly reducing the efficacy of conventional antimicrobial therapies. Increasing experimental and clinical evidence supports the presence of biofilm‐like mycobacterial communities in TB lesions, linking this growth mode to disease chronicity, treatment failure, and relapse. This review aims to provide an integrated overview of the biological and physiological states adopted by mycobacteria within biofilm microenvironments, with particular emphasis on the mechanisms underlying biofilm‐associated drug tolerance. In addition, it critically discusses therapeutic strategies designed to overcome this tolerance, focusing on synergistic antibiotic combinations and peptide–antibiotic therapies that directly disrupt biofilm architecture, enhance drug penetration, or sensitize biofilm‐embedded bacilli to antimicrobial killing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
- Vicerrectorado de Investigación, Universidad Católica de Santa María, Arequipa, Peru.
ORCID-Profile: Lourdes Serrano Garcia, Cesar Augusto Roque-Borda, Fernando Rogério Pavan, Marlus Chorilli
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- São Paulo Research Foundation
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Garcia, L. S., Roque-Borda, C. A., Pavan, F. R., & Chorilli, M. (2026). Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments. APMIS, 134(3). https://doi.org/10.1111/apm.70166
Vancouver
Garcia LS, Roque-Borda CA, Pavan FR, Chorilli M. Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments. APMIS. 2026;134(3). doi:10.1111/apm.70166
BibTeX
@article{Garcia2026,
author = {Garcia, Lourdes Serrano and Roque-Borda, Cesar Augusto and Pavan, Fernando Rogério and Chorilli, Marlus},
title = {Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments},
journal = {APMIS},
year = {2026},
volume = {134},
number = {3},
doi = {10.1111/apm.70166}
}
EUVIMED